Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
The Schmooze

Israeli Cannabis-Based Skincare Products are Here

What if we told you there was a skincare line containing cannabis?

What if it couldn’t actually get you high but can still aid in certain skin diseases?

Now that I have your attention —

In the Holy Land of Israel there are pharmacists truly doing God’s work. The Israeli-European skincare company MGC Pharmaceuticals has created a line of CBD-based products to meet the needs your skin has that can’t possibly be met without the legalization of marijuana.

In case you are still living under a rock in Abraham’s tent, you should know that Israel not only legalized medical marijuana, but it is also a world leader in Cannabis research. Saul Kaye, a pharmacist and the CEO of iCAN Israel-Cannabis, a leading cannabis tech startup accelerator, told Israeli tech publication No Camels about how research led to these high-ly acclaimed skincare products. Cannabis has been showed to aid in the management of “psoriasis, atopic dermatitis, some of the chronic autoimmune skin diseases. Once we started to see that it is effective topically, it is very natural that CBD would go into a broad range of topicals [i.e. skincare products],” he said.

Once a symbol for Bob Marley, the pervasive green leaf is now a key graphic plastered on everyday items. Israeli companies in the medical field of, er, weed, are entering into joint ventures with cosmetic companies already on the market, No Camels reported. MGC Derma, for example, is another cannabis-based cosmetic compan, co-founded by Roby Zomer.

“MGC Derma started as a pharma company. We know how many milligrams of CBD are in our products,” Zomer said. Cosmetics, he felt, were a natural next step.

MGC Pharma creates their cosmetics from cannabidiol, humans test the products, and MGC Derma sells the skincare line. The 18 formulas on the market have proven to relieve redness, dryness, and oiliness, claims Zomer. Their skincare line hit UK fashion brand, Harvey Nichols’ shelves today.

Even Israel’s famous Premier Dead Sea company will create a product line that uses CBD compounds. Mariah Carey, the celebrity face of the brand, has not yet announced whether or not she will be supporting the line.

In the words of one lone commenter on the recent news of these cannabis skincare products: “Let’s Get Groovy Israel.”

Bonnie is an intern for the Forward.

A message from our CEO & publisher Rachel Fishman Feddersen

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and polarized discourse..

Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.

—  Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at editorial@forward.com, subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.

Exit mobile version